Aalborg

• The OPTIMIST study Recruiting
  2023-505940-20-00 11 2023-09-26 osteoporosis
• A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR) Recruiting
  2024-513562-19-00 5 2023-08-30 End-Stage Kidney Disease
• Does peri-operative treatment with Tranexamic Acid reduce the early relapse rate for patients with melanoma; a randomised controlled trial Recruiting
  2022-502633-26-00 5 2023-08-25 Melanoma Surgery
• The iCaD Study Recruiting
  2022-503026-12-00 5 2023-08-22 Immune checkpoint inhibitor related colitis
• HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibod … Recruiting
  2023-504661-23-00 5 2023-06-27 Antiphospholipid antibodies
• The Danish Out-of-Hospital Cardiac Arrest study (DANOHCA) Recruiting
  2024-515997-28-00 5 2023-06-16 Patients resuscitated from out-of-hospital cardiac arrest
• Treatment with zoledronate subsequent to denosumab in osteoporosis 2 Recruiting
  2022-502621-17-00 11 2023-05-11 Osteoporosis
• The ACTION Study: ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy Recruiting
  2022-502051-56-00 5 2023-04-28 H3 K27M-mutant diffuse glioma
• Acute Subcutaneous Semaglutide in Acute Ischemic Stroke (ASSET Trial) Recruiting
  2022-501072-25-02 4 2023-04-12 Ischemic Stroke
• INVITED trial Recruiting
  2022-500906-17-01 4 2023-03-21 Type 1 diabetes
• Immunotherapy in patients with early dMMR rectal cancer. A Danish DCCG phase II trial Recruiting
  2022-500646-14-00 4 2023-01-31 cancer
• Screening and intervention for subclinical coronary artery disease in patients with type 2 diabetes: THE STENO INTEN-CT STUDY Recruiting
  2022-500143-21-01 6 2023-01-12 Type 2 diabetes
• Lithium Versus Cariprazine in the Acute Phase Treatment of Bipolar Depression (DUAG9) Recruiting
  2024-517170-20-01 6 2022-12-13 Depressive episode in bipolar disorder
• A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC and Lenalidomide (Tec-DR) and Talquetamab in Combination … Recruiting
  2023-503442-30-00 5 2022-10-14 Multiple Myeloma
• A trial to compare efficacy and tolerability of Plenvu® and Picoprep® as cleansing agents of the large bowel before colonoscopy (examination … Recruiting
  2024-518544-21-00 6 2022-09-01 The trial is about comparing the efficacy of Plenvu with Picoprep. Bot
• The Dan-DAPT trial Recruiting
  2022-500125-32-00 6 2022-06-20 Myocardial infarction
• This study is to evaluate the safety and tolerability of Epcoritamab in Combination with Anti-Neoplastic Agents in Subjects with Non-Hodgkin … Recruiting
  2023-505347-38-00 9 2022-06-13 B-cell Non-Hodgkin's lymphoma, diffuse large B-cell lymphoma
• HERES trial: Trastuzumab and standard treatment with chemo- and immunotherapy as first line treatment for HER2 positive esophageal squamous … Recruiting
  2024-516318-40-02 4 2022-02-21 Esophageal Cancer
• Study of HM15912 in subjects with Short Bowel Syndrome-associated Intestinal Failure Recruiting
  2024-515160-32-00 4 2022-02-02 Short Bowel Syndrome-associated Intestinal Failure (SBS-IF)
• Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten (CK-3773274) in Adults With Hypertrophic Cardiomyo … Recruiting
  2023-508963-58-00 4 2022-01-31 Symptomatic hypertrophic cardiomyopathy (HCM)
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting
  2023-505438-85-00 5 2022-01-12 Acute myocardial infarction (AMI)
• Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis Recruiting
  2023-504152-97-00 5 2021-11-26 Generalized Myasthenia Gravis
• Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) Recruiting
  2023-508105-24-00 5 2021-11-11 COVID-19
• Mesalamine administration to prevent development of colorectal cancer in Lynch syndrome Recruiting
  2024-514765-19-01 4 2021-08-12 Lynch syndrome, which is increasing the risk of developing colorectal

Showing 145–168 of 319 trials